Literature DB >> 818889

A model for therapeutic interventins on established coronary atherosclerosis in a nonhuman primate.

M R Malinow, O McLaughlin, L Papworth, H K Naito, L Lewis, W P McNulty.   

Abstract

The observations so far conducted in cynomologus monkeys on semipurified diets containing butter and cholesterol suggest that this nonhuman primate is an excellent model for studying the therapy of established coronary atherosclerosis. (1) This species is available at a reasonable cost and can be kept in captivity in good health for prolonged periods of time. (2) It readily accepts semipurified diets with a percentage composition similar to that of human diets in the U.S. (3) Ingestion of these diets leads quite rapidly (around 6 months) to moderate coronary atherosclerosis. More prolonged feeding leads to lesions which are histologically very similar to those in man. (4) The distribution of lesions in the main coronary arteries is similar to that in man. (5) Methods to quantify the coronary lesions are available. (6) The diets can be so modified that cholesterol levels closely resemble those in hypercholesterolemic man. (7) The monkeys are amenable to several therapeutic regimens which show promise of arresting the progress or inducing the regression of the coronary lesions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 818889     DOI: 10.1007/978-1-4614-4618-7_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Cholesterol and bile acid balance in Macaca fascicularis. Effects of alfalfa saponins.

Authors:  M R Malinow; W E Connor; P McLaughlin; C Stafford; D S Lin; A L Livingston; G O Kohler; W P McNulty
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

2.  Hemodynamic sequelae of regression of experimental atherosclerosis.

Authors:  M L Armstrong; D D Heistad; M L Marcus; D J Piegors; F M Abboud
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

Review 3.  Fish oil and the prevention and regression of atherosclerosis.

Authors:  L M Sassen; J M Lamers; P D Verdouw
Journal:  Cardiovasc Drugs Ther       Date:  1994-04       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.